Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Apellis Pharmaceuticals Inc (APLS)
NASDAQ:APLS
RESEARCH TOOLSreports
Apellis Pharmaceuticals (APLS) Stock Forecast & Price Target
759 Followers
See the Price Targets and Ratings of:
APLS Analyst Ratings
Strong Buy
11 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
APLS Stock 12 Month Forecast
Average Price Target
$72.58
▲(91.10% Upside)
| Highest Price Target$95.00 | Average Price Target$72.58 | Lowest Price Target$46.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Analyst Performance
Any
Analyst Rating
Any
Upside / Downside
Any
Action
Any
Jefferies
Assigned
07/18/24
Wells Fargo
Reiterated
07/11/24
Oppenheimer
Reiterated
07/02/24
J.P. Morgan
Reiterated
06/28/24
Bank of America Securities
Reiterated
06/28/24
Mizuho Securities
Reiterated
06/28/24
Robert W. Baird
Reiterated
06/28/24
Stifel Nicolaus
Reiterated
06/04/24
Piper Sandler
Initiated
05/31/24
H.C. Wainwright
Reiterated
05/28/24
UBS
$85
Buy
$85.00
(123.80% Upside)
Reiterated
05/24/24
Apellis shares 'undervalued' at current levels, says UBSApellis shares 'undervalued' at current levels, says UBS
TD Cowen
$95
Buy
$95.00
(150.13% Upside)
Reiterated
05/14/24
TD Cowen reiterates Buy Rating on Apellis Pharmaceuticals (APLS)TD Cowen analyst Phil Nadeau reiterated a Buy rating and $95.00 price target on Apellis Pharmaceuticals (NASDAQ: APLS).
Citi
$60
Buy
$60.00
(57.98% Upside)
Reiterated
05/13/24
Analysts Are Bullish on These Healthcare Stocks: Apellis Pharmaceuticals (APLS), TScan Therapeutics (TCRX)
Needham
$85
Buy
$85.00
(123.80% Upside)
Reiterated
05/07/24
Buy Rating Reaffirmed for Apellis Pharmaceuticals Amid Strong Syfovre Sales and Robust Financial Outlook
Wedbush
$60→$67
Hold
$67.00
(76.41% Upside)
Reiterated
02/28/24
Apellis price target raised to $67 from $60 at WedbushApellis price target raised to $67 from $60 at Wedbush
Best Analysts Covering Apellis Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy APLS and Sell After:
1 Month
xxx
Success Rate
20/30 ratings generated profit
Average Return
+9.47%
reiterated a xxx
rating 20 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +9.47% per trade.
3 Months
xxx
Success Rate
15/24 ratings generated profit
Average Return
+4.82%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of +4.82% per trade.
1 Year
Success Rate
17/30 ratings generated profit
Average Return
+13.57%
reiterated a buy rating 20 days ago
Copying Justin Kim's trades and holding each position for 1 Year would result in 56.67% of your transactions generating a profit, with an average return of +13.57% per trade.
2 Years
xxx
Success Rate
22/30 ratings generated profit
Average Return
+27.37%
reiterated a xxx
rating 20 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 73.33% of your transactions generating a profit, with an average return of +27.37% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
APLS Analyst Recommendation Trends
Rating
Mar 24
Apr 24
May 24
Jun 24
Jul 24
Strong Buy
2
9
18
20
15
Buy
23
11
8
6
6
Hold
12
10
10
10
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
37
30
36
36
28
Each month's total comprises the sum of three months' worth of ratings.
APLS Financial Forecast
APLS Stock Forecast FAQ
What is APLS’s average 12-month price target, according to analysts?
Based on analyst ratings, Apellis Pharmaceuticals Inc’s 12-month average price target is $72.58.
What is APLS’s upside potential, based on the analysts’ average price target?
Apellis Pharmaceuticals Inc has 91.10% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is APLS a Buy, Sell or Hold?
Apellis Pharmaceuticals Inc has a consensus rating of Strong Buy which is based on 11 buy ratings, 3 hold ratings and 0 sell ratings.
What is Apellis Pharmaceuticals Inc’s price target?
The average price target for Apellis Pharmaceuticals Inc is $72.58. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $95.00 ,the lowest forecast is $46.00. The average price target represents 91.10% Increase from the current price of $37.98.
The highest analyst price target is $95.00 ,the lowest forecast is $46.00. The average price target represents 91.10% Increase from the current price of $37.98.
What do analysts say about Apellis Pharmaceuticals Inc?
Apellis Pharmaceuticals Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of APLS?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.